These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38985057)

  • 1. SARS-CoV-2 clearance in term of Cycle Threshold (Ct) during first two waves of COVID-19 in Pakistan: a phenomenon of delayed viral clearance post-corticosteroid treatment.
    Uppal R; Saeed U; Uppal MR; Khan AA; Ahmad M; Piracha ZZ
    Braz J Biol; 2024; 84():e271452. PubMed ID: 38985057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: An approach to reduce the isolation period for COVID-19 patients.
    Aranha C; Patel V; Bhor V; Gogoi D
    J Med Virol; 2021 Dec; 93(12):6794-6797. PubMed ID: 34264527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study.
    Fox-Lewis A; Fox-Lewis S; Beaumont J; Drinković D; Harrower J; Howe K; Jackson C; Rahnama F; Shilton B; Qiao H; Smith KK; Morpeth SC; Taylor S; Blakiston M; Roberts S; McAuliffe G
    Pathology; 2021 Jun; 53(4):530-535. PubMed ID: 33838922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial.
    Olagunju A; Fowotade A; Olagunoye A; Ojo TO; Adefuye BO; Fagbamigbe AF; Adebiyi AO; Olagunju OI; Ladipo OT; Akinloye A; Adeagbo BA; Onayade A; Bolaji OO; Happi C; Rannard S; Owen A
    Trials; 2021 Jan; 22(1):3. PubMed ID: 33397457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic.
    Perico L; Tomasoni S; Peracchi T; Perna A; Pezzotta A; Remuzzi G; Benigni A
    EBioMedicine; 2020 Nov; 61():103069. PubMed ID: 33130396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of SARS-CoV-2 in Tears of Patients with Moderate to Severe COVID-19.
    Arora R; Goel R; Kumar S; Chhabra M; Saxena S; Manchanda V; Pumma P
    Ophthalmology; 2021 Apr; 128(4):494-503. PubMed ID: 32882309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

  • 10. Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity.
    Stankiewicz Karita HC; Dong TQ; Johnston C; Neuzil KM; Paasche-Orlow MK; Kissinger PJ; Bershteyn A; Thorpe LE; Deming M; Kottkamp A; Laufer M; Landovitz RJ; Luk A; Hoffman R; Roychoudhury P; Magaret CA; Greninger AL; Huang ML; Jerome KR; Wener M; Celum C; Chu HY; Baeten JM; Wald A; Barnabas RV; Brown ER
    JAMA Netw Open; 2022 Jan; 5(1):e2142796. PubMed ID: 35006245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 in Adults During the First and Second Wave of Coronavirus Disease 2019 Pandemic in Houston, Texas: The Potential of the Superspreader.
    Avadhanula V; Nicholson EG; Ferlic-Stark L; Piedra FA; Blunck BN; Fragoso S; Bond NL; Santarcangelo PL; Ye X; McBride TJ; Aideyan LO; Patel KD; Maurer L; Angelo LS; Piedra PA
    J Infect Dis; 2021 May; 223(9):1528-1537. PubMed ID: 33585934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of Viral Load Cycle Threshold Values in Patients with SARS-CoV-2 Associated Pneumonia with Real-Time PCR Method.
    Bakir A; Hosbul T; Cuce F; Artuk C; Taskin G; Caglayan M; Guney M; Kurkcu MF; Yildiz F; Erdal H; Erdem G
    J Infect Dev Ctries; 2021 Oct; 15(10):1408-1414. PubMed ID: 34780363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of SARS-CoV-2 PCR Cycle Threshold Values Provide Practical Insight Into Overall and Target-Specific Sensitivity Among Symptomatic Patients.
    Buchan BW; Hoff JS; Gmehlin CG; Perez A; Faron ML; Munoz-Price LS; Ledeboer NA
    Am J Clin Pathol; 2020 Sep; 154(4):479-485. PubMed ID: 32687186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cycle threshold values in SARS-CoV-2-PCR in a long-term study.
    Ade C; Pum J; Abele I; Raggub L; Bockmühl D; Zöllner B
    J Clin Virol; 2021 May; 138():104791. PubMed ID: 33725648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Symptoms and RNA Levels in Children and Adults With SARS-CoV-2 Infection in the Community Setting.
    Chung E; Chow EJ; Wilcox NC; Burstein R; Brandstetter E; Han PD; Fay K; Pfau B; Adler A; Lacombe K; Lockwood CM; Uyeki TM; Shendure J; Duchin JS; Rieder MJ; Nickerson DA; Boeckh M; Famulare M; Hughes JP; Starita LM; Bedford T; Englund JA; Chu HY
    JAMA Pediatr; 2021 Oct; 175(10):e212025. PubMed ID: 34115094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease.
    Lv Y; Ma Y; Si Y; Zhu X; Zhang L; Feng H; Tian D; Liao Y; Liu T; Lu H; Ling Y
    Biosci Trends; 2021 May; 15(2):93-99. PubMed ID: 33776018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biochemical indexes of 11 COVID-19 patients and the genome sequence analysis of the tested SARS-CoV-2.
    Yu Z; Wu H; Huang Q; Zhong Z
    J Clin Lab Anal; 2021 Dec; 35(12):e24088. PubMed ID: 34741347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Flexible Regression Modeling Approach Applied to Observational Laboratory Virological Data Suggests That SARS-CoV-2 Load in Upper Respiratory Tract Samples Changes with COVID-19 Epidemiology.
    Pellegrinelli L; Luconi E; Marano G; Galli C; Delbue S; Bubba L; Binda S; Castaldi S; Biganzoli E; Pariani E; Boracchi P
    Viruses; 2023 Sep; 15(10):. PubMed ID: 37896765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective analysis of 12,400 SARS-CoV-2 RNA tests in patients with COVID-19 in Wuhan.
    Wang J; Bao A; Gu J; He X; Wu Z; Qiao B; Chen Z; Xiong L; Zhang Y; Zheng H; Li F; Zhao Z; Mei S; Tong Y
    Medicine (Baltimore); 2021 May; 100(20):e25916. PubMed ID: 34011059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequencing of SARS-CoV-2 in local transmission cases through Oxford Nanopore MinION platform from Karachi Pakistan.
    Mukry SN; Ahmed S; Raza Bukhari A; Shahni A; Sufaida G; Naz A; Shamsi TS
    J Infect Dev Ctries; 2021 Oct; 15(10):1376-1383. PubMed ID: 34780358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.